V. Figala

发表

(H+-K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 2. The reaction cascade induced by treatment with acids. Formation of 5H-pyrido[1',2':4,5][1,2,4]thiadiazino[2,3-a]benzimidazol-13-ium salts and their reactions with thiols

J. Senn‐Bilfinger, U. Krueger, E. Sturm, 1987 .

(H+-K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 3. Evidence for the involvement of a sulfenic acid in their reactions

J. Senn‐Bilfinger, U. Krueger, E. Sturm, 1990 .

Characterization of eltenac and novel COX-2 selective thiopheneacetic acid analogues in vitro and in vivo.

F. Dullweber, M. Herrmann, T. Klein, 2008, Biochemical pharmacology.

(H+-K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 1. Their reaction with thiols under acidic conditions. Disulfide containing 2-pyridiniobenzimidazolides as mimics for the inhibited enzyme

J. Senn‐Bilfinger, U. Krueger, E. Sturm, 1987 .

Affinity and selectivity of biperiden enantiomers for muscarinic receptor subtypes.

M. Eltze, V. Figala, 1988, European journal of pharmacology.

Characterization of the dexniguldipine binding site in the multidrug resistance-related transport protein P-glycoprotein by photoaffinity labeling and mass spectrometry.

C. Borchers, M. Przybylski, V. Gekeler, 2002, Molecular pharmacology.

Antioxidant and neutrophil-inhibiting properties of new 2-O-methyl-6-(alkylthio)ascorbic acid derivatives.

V. Ullrich, E. Schmid, V. Figala, 1993, Journal of medicinal chemistry.

(H+,K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate.

W. Simon, B Kohl, E Sturm, 1992, Journal of medicinal chemistry.

Acid activation of (H+−K+)-ATPase inhibiting 2-(2-pyridylmethyl-sulphinyl)benzimidazoles: isolation and characterization of the thiophilic active principlë and its reactions

E. Sturm, V. Figala, K. Klemm, 1986 .